Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor
Desmoplastic small round cell tumor (DRSCT) is a highly aggressive primitive sarcoma that primarily affects adolescent and young adult males. The 5-year survival rate is 15-30% and few curative treatment options exist. Although there is no standard treatment for DSRCT, patients are most often treate...
Guardado en:
Autores principales: | Madelyn Espinosa-Cotton, Nai-Kong V. Cheung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/464a5e21d0bd42d384162eed6cb0f7ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A rare cause of bilateral pleural effusion – desmoplastic small round cell tumor
por: Archana Baburao, et al.
Publicado: (2021) -
Differential diagnosis and treatment of rare forms of primary peritoneal tumors – solitary fibrous and desmoplastic small round cell tumors
por: Amir G. Abdullaev, et al.
Publicado: (2021) -
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
por: Hawkins ER, et al.
Publicado: (2021) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Sergey Kulemzin, et al.
Publicado: (2021) -
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
por: Jessica Waibl Polania, et al.
Publicado: (2021)